Cardiac Biotech Solutions, Inc. (CBSC)
0.035
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Cardiac Biotech Solutions Profit Margin (Quarterly) : -341.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -341.3% |
| March 31, 2026 | -254.3% |
| December 31, 2025 | -1.42K% |
| September 30, 2025 | -150.6% |
| June 30, 2025 | -422.8% |
| March 31, 2025 | -5.78K% |
| December 31, 2024 | -5.73K% |
| September 30, 2024 | -3.05K% |
| June 30, 2024 | -2.28K% |
| March 31, 2024 | -3.19K% |
| December 31, 2023 | -1.76K% |
| September 30, 2023 | -4.43K% |
| June 30, 2023 | -372.2% |
| March 31, 2023 | -14.97K% |
| December 31, 2022 | |
| September 30, 2022 | -6.80K% |
| June 30, 2022 | -658.4% |
| March 31, 2022 | -2.74K% |
| December 31, 2021 | -154.0K% |
| September 30, 2021 | -3.12K% |
| Date | Value |
|---|---|
| June 30, 2021 | -7.26K% |
| March 31, 2021 | -19.43K% |
| December 31, 2020 | -16.92K% |
| September 30, 2020 | -25.79K% |
| June 30, 2020 | -888.3% |
| March 31, 2020 | -54.69% |
| December 31, 2019 | |
| June 30, 2019 | -126.1% |
| March 31, 2019 | |
| December 31, 2018 | -176.2% |
| September 30, 2018 | -887.2% |
| June 30, 2018 | -1.28K% |
| March 31, 2018 | -2.71K% |
| December 31, 2017 | -6.32K% |
| September 30, 2017 | -1.96K% |
| June 30, 2017 | -1.44K% |
| March 31, 2017 | -2.44K% |
| December 31, 2016 | -1.48K% |
| September 30, 2016 | -1.35K% |
| June 30, 2016 | -334.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vyome Holdings, Inc. | -2.67K% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -213.4% |
| Operating Margin (Quarterly) | -290.5% |
| Return on Net Operating Assets | -507.2% |